Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Voronkov

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Neurochemistry International|December 14, 2020
Does a hypoxic injury from a non-fatal overdose lead to an Alzheimer Disease?Michael Voronkov, Benjamin Cocchiaro, Jeffry B Stock
Future Medicinal Chemistry|June 8, 2011
Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's diseaseMichael Voronkov, Steven P Braithwaite, Jeffry B Stock
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 30, 2021
NB-33, a bioreversible opioid derivative of Nalbuphine, shows enhanced pharmacodynamicsMichael Voronkov, Georgiy Nikonov, Roman Naumov, et al.
Neurochemistry International|February 21, 2012
Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson's diseaseSteven P Braithwaite, Michael Voronkov, Jeffry B Stock, et al.
The International Journal on Drug Policy|July 27, 2021
A vicious cycle of neuropathological, cognitive and behavioural sequelae of repeated opioid overdoseMichael Voronkov, Janna Ataiants, Benjamin Cocchiaro, et al.
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Does Kappa Agonism Improve Reversal of 'Tranq-Dope' Overdose? Evidence from a Rodent ModelMichael Voronkov, Mihai Cernea, Cristina Stefanut, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Is Fentanyl Rebound an Intrinsic Feature of Naloxone Reversal?Michael Voronkov, Georgiy Nikonov, Melda Uzbil, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Nalbuphine Potentiates Reversal of Fentanyl Overdose by NaloxoneMihai Cernea, Georgiy Nikonov, Janna Ataiants, et al.
International Journal of Pharmaceutics|December 1, 2021
Modifying naloxone to reverse fentanyl-induced overdoseMichael Voronkov, Georgiy Nikonov, Janna Ataiants, et al.
Neurobiology of Aging|July 19, 2014
Therapeutic benefits of a component of coffee in a rat model of Alzheimer's diseaseGustavo Basurto-Islas, Julie Blanchard, Yunn Chyn Tung, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Neurochemistry International|December 14, 2020
Does a hypoxic injury from a non-fatal overdose lead to an Alzheimer Disease?Michael Voronkov, Benjamin Cocchiaro, Jeffry B Stock
Future Medicinal Chemistry|June 8, 2011
Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's diseaseMichael Voronkov, Steven P Braithwaite, Jeffry B Stock
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 30, 2021
NB-33, a bioreversible opioid derivative of Nalbuphine, shows enhanced pharmacodynamicsMichael Voronkov, Georgiy Nikonov, Roman Naumov, et al.
Neurochemistry International|February 21, 2012
Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson's diseaseSteven P Braithwaite, Michael Voronkov, Jeffry B Stock, et al.
The International Journal on Drug Policy|July 27, 2021
A vicious cycle of neuropathological, cognitive and behavioural sequelae of repeated opioid overdoseMichael Voronkov, Janna Ataiants, Benjamin Cocchiaro, et al.
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Does Kappa Agonism Improve Reversal of 'Tranq-Dope' Overdose? Evidence from a Rodent ModelMichael Voronkov, Mihai Cernea, Cristina Stefanut, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Is Fentanyl Rebound an Intrinsic Feature of Naloxone Reversal?Michael Voronkov, Georgiy Nikonov, Melda Uzbil, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Nalbuphine Potentiates Reversal of Fentanyl Overdose by NaloxoneMihai Cernea, Georgiy Nikonov, Janna Ataiants, et al.
International Journal of Pharmaceutics|December 1, 2021
Modifying naloxone to reverse fentanyl-induced overdoseMichael Voronkov, Georgiy Nikonov, Janna Ataiants, et al.
Neurobiology of Aging|July 19, 2014
Therapeutic benefits of a component of coffee in a rat model of Alzheimer's diseaseGustavo Basurto-Islas, Julie Blanchard, Yunn Chyn Tung, et al.
Pageof 3